LONG-TERM SAFETY AND TOLERABILITY OF BREXPIPRAZOLE IN PATIENTS WITH SCHIZOPHRENIA

被引：4
|
作者：
Hakala, Mika [1 ]
Gislum, Mette [1 ]
Skuban, Aleksandar [2 ]
Meehan, Stine [1 ]
机构：
[1] H Lundbeck & Co AS, Copenhagen, Denmark
[2] Otsuka Pharmaceut Dev & Commercializat Inc, San Francisco, CA USA
来源：
SCHIZOPHRENIA BULLETIN | 2018年 / 44卷
关键词：
D O I：
10.1093/schbul/sby015.234
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
O7.5
引用
收藏
页码：S94 / S95
页数：2
相关论文
共 50 条
  • [1] Safety and tolerability of brexpiprazole in adults with schizophrenia: results of an openlabel, long-term study
    Weiss, C.
    Forbes, A.
    Hobart, M.
    Ouyang, J.
    Pfister, S.
    Eriksson, H.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S953 - S954
  • [2] Long-term safety and tolerability of paliperidone palmitate in patients with schizophrenia
    Gopal, S.
    Vijapurkar, U.
    Lim, P.
    Morozova, M.
    Eerdekens, M.
    Hough, D.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 218 - 219
  • [3] Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia
    Nasrallah, Henry A.
    Aquila, Ralph
    Du, Yangchun
    Stanford, Arielle D.
    Claxton, Amy
    Weiden, Peter J.
    [J]. CNS SPECTRUMS, 2019, 24 (04) : 395 - 403
  • [4] A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia
    Forbes, Andy
    Hobart, Mary
    Ouyang, John
    Shi, Lily
    Pfister, Stephanie
    Hakala, Mika
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2018, 21 (05): : 433 - 441
  • [5] A Long-Term Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults With Schizophrenia
    Forbes, Robert
    Hobart, Mary
    Ouyang, John
    Pfister, Stephanie
    Hakala, Mika
    [J]. NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S409 - S410
  • [6] SAFETY AND TOLERABILITY OF CARIPRAZINE IN THE LONG-TERM TREATMENT OF SCHIZOPHRENIA
    Durgam, Suresh
    Cutler, Andrew J.
    Wang, Yao
    Migliore, Raffaele
    Lu, Kaifeng
    Laszlovszky, Istvan
    Nagy, Krisztian
    [J]. SCHIZOPHRENIA RESEARCH, 2014, 153 : S272 - S272
  • [7] Long-term safety, tolerability and clinical improvement with quetiapine in elderly patients with schizophrenia
    Vinogradov, S
    Salzman, C
    Pültz, JA
    Yeung, PP
    [J]. SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 207 - 207
  • [8] Long-term tolerability and safety of aripiprazole in pediatric patients with schizophrenia or bipolar I disorder
    Nyilas, M.
    Correll, C.
    Werner, C.
    Forbes, R.
    Johnson, B.
    Aurang, C.
    Jin, N.
    Owen, R.
    Iwamoto, T.
    Carson, W.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 133 - 134
  • [9] Adjunctive brexpiprazole for elderly patients with major depressive disorder: An open-label, long-term safety and tolerability study
    Lepola, Ulla
    Hefting, Nanco
    Zhang, Doris
    Hobart, Mary
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 33 (10) : 1403 - 1410
  • [10] Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder
    Lindenmayer, Jean-Pierre
    Khan, Akbar
    Eerdekens, Marielle
    Van Hove, Ilse
    Kushner, Stuart
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (02) : 138 - 144
12345